Mr. Stern is Managing Director and Head of the firm’s Healthcare Group, specializing in Mergers & Acquisitions, Capital Raising and Valuations/Fairness Opinions. With over 25 years’ experience, Mr. Stern has worked with early-stage companies to multi-billion dollar conglomerates in healthcare services, healthcare IT (HCIT), medical products & supplies and nutraceuticals, as well as medical device and biopharmaceutical companies.
Mr. Stern is the leading investment banker in the fertility (IVF) sector, having closed numerous transactions including the sale of IGENOMIX, the merger of RMA of NJ and IVI of Spain, the sale of Advanced Fertility of Chicago to Prelude Fertility, and the sale of Santa Monica Fertility to Webster Equity Partners.
Before joining Dresner Partners, Mr. Stern was a Managing Director in Healthcare Investment Banking at Morgan Joseph. He has also held positions with SMH Capital (Sanders Morris Harris), Glocap Advisors, Needham & Co., Schroders plc (Wertheim Schroder), and Salomon Brothers. In addition, Mr. Stern worked for the M&A Transactions Group at Deloitte & Touche and was a Certified Public Accountant (C.P.A.) with Ernst and Whinney (now Ernst & Young).
M.B.A. Finance, New York University
B.A. Accounting, Franklin and Marshall College
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.